EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Effects of (−)‐MBP, a novel 5‐HT 2C agonist and 5‐HT 2A/2B antagonist/inverse agonist on brain activity: A phMRI study on awake mice

Preeti K Sathe, Gargi R Ramdasi, Kaylie Giammatteo, Harvens Beauzile, Shuyue Wang, Heng Zhang, Praveen Kulkarni, Raymond G Booth, Craig F Ferris iD

Pharmacology Research & Perspectives · 2023

DOI: 10.1002/prp2.1144 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacology Research & Perspectives, 2023. Verfasst von Preeti K Sathe und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department Pharmaceutical Sciences, Northeastern University, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Serotonin, Drug Inverse Agonism. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDA NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A novel serotonin ligand (−)‐MBP was developed for the treatment of schizophrenia that has 5‐HT 2A/2B antagonist activity together with 5‐HT 2C agonist activity. The multi‐functional activity of this novel drug candidate was characterized using pharmacological magnetic resonance imaging. It was hypothesized (−)‐MBP would affect activity in brain areas associated with sensory perception. Adult male mice were given one of three doses of (−)‐MBP (3.0, 10, 18 mg/kg) or vehicle while fully awake during the MRI scanning session and imaged for 15 min post I.P. injection. BOLD functional imaging was used to follow changes in global brain activity. Data for each treatment were registered to a 3D MRI mouse brain atlas providing site‐specific information on 132 different brain areas. There was a dose‐dependent decrease in positive BOLD signal in numerous brain regions, especially thalamus, cerebrum, and limbic cortex. The 3.0 mg/kg dose had the greatest effect on positive BOLD while the 18 mg/kg dose was less effective. Conversely, the 18 mg/kg dose showed the greatest negative BOLD response while the 3.0 mg/kg showed the least. The prominent activation of the thalamus and cerebrum included the neural circuitry associated with Papez circuit of emotional experience. When compared to vehicle, the 3.0 mg dose affected all sensory modalities, for example, olfactory, somatosensory, motor, and auditory except for the visual cortex. These findings show that (−)‐MBP, a ligand with both 5‐HT 2A/2B antagonist and 5‐HT 2C agonist activities, interacts with thalamocortical circuitry and impacts areas involved in sensory perception.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SerotoninDrug Inverse AgonismMiceMaleAnimalsWakefulnessLigandsBrain

Stichwörter der Autor:innen

BOLD imagingPapez circuitschizophreniaserotoninthalamus

Substanzen

SerotoninLigands

Autor:innen und Institutionen

  • Department Pharmaceutical Sciences, Northeastern University, Boston, Massachusetts, USA.
  • Center for Translational Neuroscience, Northeastern University, Boston, Massachusetts, USA.
  • Department Psychology, Northeastern University, Boston, Massachusetts, USA.

ORCID-Profile: Craig F Ferris

Förderung

  • NIDA NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Sathe, P. K., Ramdasi, G. R., Giammatteo, K., Beauzile, H., Wang, S., Zhang, H., Kulkarni, P., Booth, R. G., & Ferris, C. F. (2023). Effects of (−)‐MBP, a novel 5‐HT 2C agonist and 5‐HT 2A/2B antagonist/inverse agonist on brain activity: A phMRI study on awake mice. Pharmacology Research & Perspectives. https://doi.org/10.1002/prp2.1144

Vancouver

Sathe PK, Ramdasi GR, Giammatteo K, Beauzile H, Wang S, Zhang H, et al. Effects of (−)‐MBP, a novel 5‐HT 2C agonist and 5‐HT 2A/2B antagonist/inverse agonist on brain activity: A phMRI study on awake mice. Pharmacology Research & Perspectives. 2023. doi:10.1002/prp2.1144

BibTeX
@article{Sathe2023,
  author = {Sathe, Preeti K and Ramdasi, Gargi R and Giammatteo, Kaylie and Beauzile, Harvens and Wang, Shuyue and Zhang, Heng and Kulkarni, Praveen and Booth, Raymond G and Ferris, Craig F},
  title = {Effects of (−)‐MBP, a novel 5‐HT 2C agonist and 5‐HT 2A/2B antagonist/inverse agonist on brain activity: A phMRI study on awake mice},
  journal = {Pharmacology Research & Perspectives},
  year = {2023},
  doi = {10.1002/prp2.1144}
}
Kostenlos starten →